C2ORF69 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.314600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.945000E-01
Normal-vs-Stage2
9.382800E-01
Normal-vs-Stage3
3.164100E-02
Normal-vs-Stage4
2.661600E-01
Stage1-vs-Stage2
9.665600E-01
Stage1-vs-Stage3
9.029800E-02
Stage1-vs-Stage4
1.965170E-01
Stage2-vs-Stage3
1.178840E-03
Stage2-vs-Stage4
2.345600E-01
Stage3-vs-Stage4
8.221300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.133200E-01
Normal-vs-AfricanAmerican
7.449600E-01
Normal-vs-Asian
7.107800E-01
Caucasian-vs-AfricanAmerican
4.664800E-01
Caucasian-vs-Asian
6.194200E-01
AfricanAmerican-vs-Asian
3.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.047400E-01
Normal-vs-Female
9.215600E-01
Male-vs-Female
1.964790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.282400E-01
Normal-vs-Age(41-60Yrs)
6.718200E-01
Normal-vs-Age(61-80Yrs)
7.923800E-01
Normal-vs-Age(81-100Yrs)
2.889400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.296600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.410200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.660400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.428450E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.553800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.111200E-01
Normal-vs-Daily Drinker
4.339400E-01
Normal-vs-Weekly Drinker
8.810400E-01
Normal-vs-Occasional Drinker
6.684600E-01
Normal-vs-Social Drinker
9.596000E-01
Non Drinker-vs-Daily Drinker
5.191800E-01
Non Drinker-vs-Weekly Drinker
3.526200E-01
Non Drinker-vs-Occasional Drinker
1.162630E-01
Non Drinker-vs-Social Drinker
5.501800E-01
Daily Drinker-vs-Weekly Drinker
2.138400E-01
Daily Drinker-vs-Occasional Drinker
2.999900E-02
Daily Drinker-vs-Social Drinker
2.339800E-01
Weekly Drinker-vs-Occasional Drinker
7.387200E-01
Weekly Drinker-vs-Social Drinker
7.286800E-01
Occasional Drinker-vs-Social Drinker
4.084400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.351780E-01
Normal-vs-Grade 2
2.970100E-02
Normal-vs-Grade 3
6.648200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.256800E-01
Grade 1-vs-Grade 3
5.156600E-01
Grade 1-vs-Grade 4
1.351780E-01
Grade 2-vs-Grade 3
6.098600E-01
Grade 2-vs-Grade 4
2.970100E-02
Grade 3-vs-Grade 4
6.648200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.743200E-01
Normal-vs-NonDiabetic
8.494800E-01
Diabetic-vs-NonDiabetic
7.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.146200E-01
Normal-vs-NoPancreatitis
9.168800E-01
Pancreatitis-vs-NoPancreatitis
4.370400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.752000E-01
Normal-vs-N1
9.828000E-01
N0-vs-N1
3.933800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.935000E-01
Normal-vs-TP53-NonMutant
9.082200E-01
TP53-Mutant-vs-TP53-NonMutant
9.513800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
